First evaluation of a 99mTc-tricarbonyl complex, 99mTc(CO)3(LAN), as a new renal radiopharmaceutical in humans.
about
New Monodentate Amidine Superbasic Ligands with a Single Configuration infac-[Re(CO)3(5,5′- or 6,6′-Me2bipyridine)(amidine)]BF4ComplexesComplexes possessing rare "tertiary" sulfonamide nitrogen-to-metal bonds of normal length: fac-[Re(CO)3(N(SO2R)dien)]PF6 complexes with hydrophilic sulfonamide ligands.Several novel N-donor tridentate ligands formed in chemical studies of new fac-Re(CO)3 complexes relevant to fac-99mTc(CO)3 radiopharmaceuticals: attack of a terminal amine on coordinated acetonitrile.(99m)Tc(CO)3(NTA): a (99m)Tc renal tracer with pharmacokinetic properties comparable to those of (131)I-OIH in healthy volunteers.Preclinical evaluation of 99mTc(CO)3-aspartic-N-monoacetic acid, a renal radiotracer with pharmacokinetic properties comparable to 131I-o-iodohippurate.Coordination modes of multidentate ligands in fac-[Re(CO)(3)(polyaminocarboxylate)] analogues of (99m)Tc radiopharmaceuticals. dependence on aqueous solution reaction conditionsInitial Evaluation of (99m)Tc(CO)3(ASMA) as a Renal Tracer in Healthy Human Volunteers.Formation of a metal-to-nitrogen bond of normal length by a neutral sufonamide group within a tridentate ligand. A new approach to radiopharmaceutical bioconjugation.Initial evaluation of new 99mTc(CO)3 renal imaging agents having carboxyl-rich thioether ligands and chemical characterization of ReCO3 analogues.99mTc(CO)3-nitrilotriacetic acid: a new renal radiopharmaceutical showing pharmacokinetic properties in rats comparable to those of 131I-OIH.99mTc(CO)3(NTA) and 131I-OIH: comparable plasma clearances in patients with chronic kidney disease.Monoanionic 99mTc-tricarbonyl-aminopolycarboxylate complexes with uncharged pendant groups: Radiosynthesis and evaluation as potential renal tubular tracers.Re(CO)3([18F]FEDA), a novel 18F PET renal tracer: Radiosynthesis and preclinical evaluation.
P2860
Q28468174-322C3B76-4CE7-4AB0-A3E4-24FDE9AD0538Q30728428-F9400C47-A5EF-46E8-A4CE-EAE9F260D71AQ33754787-C37CBD1B-5DE9-484E-B291-D04925ED11D1Q33779838-BD655330-CFDB-46A2-B32A-8882551DE89BQ33781025-5D6A1E1C-F429-4464-B1B1-9CCCB7E59429Q33819450-B3C35576-69E5-45D7-9253-34CA30FD0521Q34090925-9B63074F-73A7-4897-97DF-BFCBF3054819Q35734581-4ABF4CC1-F72D-481D-B8F8-5A1699CC4695Q36154901-EE9F5101-B75A-45EB-8D03-C438E1201FA6Q37295227-E5886F6D-DC1C-4BF8-B99A-E2CB2A601C80Q37707797-93105AB1-8A8B-481A-AF7E-FDF3F37E5BD9Q46429614-8DBEF398-5CA8-46C5-A75F-A9759F85F0F2Q49790921-66956637-CA3B-4777-9097-59F2DD4E945B
P2860
First evaluation of a 99mTc-tricarbonyl complex, 99mTc(CO)3(LAN), as a new renal radiopharmaceutical in humans.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
First evaluation of a 99mTc-tr ...... radiopharmaceutical in humans.
@ast
First evaluation of a 99mTc-tr ...... radiopharmaceutical in humans.
@en
type
label
First evaluation of a 99mTc-tr ...... radiopharmaceutical in humans.
@ast
First evaluation of a 99mTc-tr ...... radiopharmaceutical in humans.
@en
prefLabel
First evaluation of a 99mTc-tr ...... radiopharmaceutical in humans.
@ast
First evaluation of a 99mTc-tr ...... radiopharmaceutical in humans.
@en
P2093
P2860
P1476
First evaluation of a 99mTc-tr ...... radiopharmaceutical in humans
@en
P2093
Andrew Taylor
Eugene Malveaux
Haiyang He
Luigi G Marzilli
Malgorzata Lipowska
Xiaolong Xu
P2860
P304
P407
P577
2006-06-01T00:00:00Z